Glaukos (GKOS) Return on Capital Employed (QoQ) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Glaukos | 6.00 Bn | 5.90 Bn | 117.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -14.00 |
| Dec 31, 2025 | -517.00 |
| Sep 30, 2025 | 92.00 |
| Jun 30, 2025 | 80.00 |
| Mar 31, 2025 | 214.00 |
| Dec 31, 2024 | 1,205.00 |
| Sep 30, 2024 | 30.00 |
| Jun 30, 2024 | -25.00 |
| Mar 31, 2024 | -80.00 |
| Dec 31, 2023 | -80.00 |
| Sep 30, 2023 | -95.00 |
| Jun 30, 2023 | 49.00 |
| Mar 31, 2023 | -470.00 |
| Dec 31, 2022 | -189.00 |
| Sep 30, 2022 | -345.00 |
| Jun 30, 2022 | -235.00 |
| Mar 31, 2022 | 218.00 |
| Dec 31, 2021 | -64.00 |
| Sep 30, 2021 | 461.00 |
| Jun 30, 2021 | 492.00 |
| Mar 31, 2021 | 81.00 |
| Mar 31, 2020 | -354.00 |
| Dec 31, 2019 | -307.00 |
| Sep 30, 2019 | -123.00 |
| Jun 30, 2019 | 26.00 |
| Mar 31, 2019 | 182.00 |
| Dec 31, 2018 | 149.00 |
| Sep 30, 2018 | -466.00 |
| Jun 30, 2018 | -23.00 |
| Mar 31, 2018 | -259.00 |
| Dec 31, 2017 | 9.00 |
| Sep 30, 2017 | -13.00 |
| Jun 30, 2017 | -491.00 |
| Mar 31, 2017 | -46.00 |
| Dec 31, 2016 | 205.00 |
| Sep 30, 2016 | 261.00 |
| Jun 30, 2016 | 765.00 |
| Mar 31, 2016 | 201.00 |
| Dec 31, 2015 | 226.00 |